DBV Technologies (DBVT) Shares Outstanding (2015 - 2026)

DBV Technologies (DBVT) posted quarterly Shares Outstanding (Entity) of $433.5 million for Q2 2026, up 216.51% year-on-year from $137.0 million in Q2 2025, and up 1.22% on a QoQ basis from $428.3 million in Q1 2026.

DBV Technologies (DBVT) Shares Outstanding (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Shares Outstanding (Entity) for 12 consecutive years, with $433.5 million the latest figure, recorded in Q2 2026.

  • Quarterly Shares Outstanding (Entity) rose 216.51% year-over-year to $433.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $433.5 million (up 216.51% YoY) and the FY2025 annual result came in at $139.6 million, up 35.71% from the prior year.
  • Shares Outstanding (Entity) improved to $433.5 million in Q2 2026 per DBVT's latest filing, from $428.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for DBVT reached as high as $433.5 million in Q2 2026 and fell as low as $5.5 million in Q1 2022.
  • A 5-year average of $88.7 million and a median of $14.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 0.29% — and 2025, when it jumped 966.62%.
  • Year by year, Shares Outstanding (Entity) stood at $7.7 million in 2022, then climbed by 24.61% to $9.6 million in 2023, then jumped by 966.53% to $102.8 million in 2024, then surged by 35.71% to $139.6 million in 2025, then jumped by 210.61% to $433.5 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $433.5 million, $428.3 million, and $139.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - 433.54 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 433.54 Mn
Mar 31, 2026 428.30 Mn
Dec 31, 2025 139.57 Mn
Sep 30, 2025 136.81 Mn
Jun 30, 2025 134.48 Mn
Mar 31, 2025 102.62 Mn
Dec 31, 2024 97.00 Mn
Sep 30, 2024 19.24 Mn
Jun 30, 2024 19.23 Mn
Mar 31, 2024 9.62 Mn
Dec 31, 2023 9.51 Mn
Sep 30, 2023 9.61 Mn
Jun 30, 2023 9.43 Mn
Mar 31, 2023 9.40 Mn
Dec 31, 2022 7.74 Mn
Sep 30, 2022 9.39 Mn
Jun 30, 2022 6.60 Mn
Mar 31, 2022 5.49 Mn
Dec 31, 2021 5.49 Mn
Sep 30, 2021 5.49 Mn